Quest Partners LLC Boosts Stake in National Research Co. (NASDAQ:NRC)

Quest Partners LLC lifted its holdings in National Research Co. (NASDAQ:NRC) by 45,175.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,055 shares of the company’s stock after purchasing an additional 9,035 shares during the quarter. Quest Partners LLC’s holdings in National Research were worth $207,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the business. Gladius Capital Management LP grew its holdings in shares of National Research by 164.5% in the third quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock worth $70,000 after acquiring an additional 1,908 shares during the period. Seizert Capital Partners LLC grew its holdings in National Research by 53.9% during the third quarter. Seizert Capital Partners LLC now owns 17,668 shares of the company’s stock valued at $404,000 after purchasing an additional 6,190 shares during the period. GSA Capital Partners LLP bought a new stake in National Research during the third quarter valued at about $330,000. Principal Financial Group Inc. bought a new stake in National Research during the third quarter valued at about $248,000. Finally, US Bancorp DE grew its holdings in National Research by 2.2% during the third quarter. US Bancorp DE now owns 45,932 shares of the company’s stock valued at $1,050,000 after purchasing an additional 992 shares during the period. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Performance

NASDAQ:NRC opened at $19.48 on Thursday. The stock has a 50-day simple moving average of $19.81 and a two-hundred day simple moving average of $22.84. National Research Co. has a 52-week low of $17.62 and a 52-week high of $42.18. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The firm has a market capitalization of $457.31 million, a PE ratio of 17.29 and a beta of 0.51.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Friday, October 25th. The company reported $0.24 EPS for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The business had revenue of $35.82 million for the quarter.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a $0.12 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.46%. National Research’s dividend payout ratio is currently 42.48%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.